2型糖尿病患者-话题@MedSci

#2型糖尿病患者#

722篇内容 | 7045人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1383790, encodeId=f9011383e9068, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者循环中血小板相关和糖尿病相关microRNAs的变化, objectType=article, longId=728696, objectId=e3ebe28696d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3ebe28696d8, replyNumber=0, likeNumber=74, createdTime=2022-06-07, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3ebe28696d8, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者循环中血小板相关和糖尿病相关microRNAs的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3ebe28696d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383789, encodeId=46ca1383e8941, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Ann Intern Med：钠-葡萄糖协同转运蛋白-2抑制剂与二甲双胍治疗2型糖尿病患者的心血管结局比较, objectType=article, longId=728165, objectId=9339e28165c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9339e28165c0, replyNumber=0, likeNumber=90, createdTime=2022-05-31, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9339e28165c0, moduleTitle=Ann Intern Med：钠-葡萄糖协同转运蛋白-2抑制剂与二甲双胍治疗2型糖尿病患者的心血管结局比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9339e28165c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383788, encodeId=7ed81383e88d4, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者体重减轻程度和体重变异性与死亡率和主要心血管事件的关系, objectType=article, longId=727865, objectId=1076e2786521, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1076e2786521, replyNumber=0, likeNumber=64, createdTime=2022-05-27, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1076e2786521, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者体重减轻程度和体重变异性与死亡率和主要心血管事件的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1076e2786521)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383786, encodeId=60921383e86b1, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=JCEM：舒张压和ACR是2型糖尿病患者动脉硬化可改变的危险因素, objectType=article, longId=727628, objectId=9a17e27628b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a17e27628b7, replyNumber=0, likeNumber=81, createdTime=2022-05-25, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a17e27628b7, moduleTitle=JCEM：舒张压和ACR是2型糖尿病患者动脉硬化可改变的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a17e27628b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383787, encodeId=66bf1383e875c, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=DOM：三联疗法口服药物控制不佳的2型糖尿病患者加用替格列汀的有效性和安全性, objectType=article, longId=727370, objectId=0f88e2737005, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f88e2737005, replyNumber=0, likeNumber=59, createdTime=2022-05-21, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f88e2737005, moduleTitle=DOM：三联疗法口服药物控制不佳的2型糖尿病患者加用替格列汀的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f88e2737005)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383785, encodeId=54b21383e8586, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Stroke：索马鲁肽对2型糖尿病患者卒中亚型的影响, objectType=article, longId=727299, objectId=7b46e27299cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b46e27299cd, replyNumber=0, likeNumber=82, createdTime=2022-05-20, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b46e27299cd, moduleTitle=Stroke：索马鲁肽对2型糖尿病患者卒中亚型的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b46e27299cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383784, encodeId=46aa1383e8432, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=DOM：固定比例的甘精胰岛素联合利司那肽(iGlarLixi)可以改善2型糖尿病患者ß-细胞功能, objectType=article, longId=727226, objectId=ced0e27226ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced0e27226ad, replyNumber=0, likeNumber=88, createdTime=2022-05-19, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced0e27226ad, moduleTitle=DOM：固定比例的甘精胰岛素联合利司那肽(iGlarLixi)可以改善2型糖尿病患者ß-细胞功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced0e27226ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383783, encodeId=44d51383e8376, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：LY2963016甘精胰岛素和Lantus®甘精胰岛素在中国1型和2型糖尿病患者中的免疫原性, objectType=article, longId=727110, objectId=f6d9e2711026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6d9e2711026, replyNumber=0, likeNumber=51, createdTime=2022-05-18, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6d9e2711026, moduleTitle=Diabetes Obes Metab：LY2963016甘精胰岛素和Lantus®甘精胰岛素在中国1型和2型糖尿病患者中的免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6d9e2711026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383782, encodeId=03bc1383e8299, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=BMC Med：成人2型糖尿病患者的糖尿病肾病和卒中风险, objectType=article, longId=726503, objectId=a970e2650338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a970e2650338, replyNumber=0, likeNumber=61, createdTime=2022-05-11, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a970e2650338, moduleTitle=BMC Med：成人2型糖尿病患者的糖尿病肾病和卒中风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a970e2650338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383780, encodeId=be361383e804a, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：达格列净、艾塞那肽及其联合应用于2型糖尿病患者降压作用的机制, objectType=article, longId=726070, objectId=b59ee2607052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b59ee2607052, replyNumber=0, likeNumber=61, createdTime=2022-05-05, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b59ee2607052, moduleTitle=Cardiovasc Diabetol：达格列净、艾塞那肽及其联合应用于2型糖尿病患者降压作用的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b59ee2607052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383779, encodeId=7bdb1383e794e, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：CT血管成像时冠脉周围脂肪组织密度高可预测2型糖尿病患者的心血管事件, objectType=article, longId=725592, objectId=7589e2559265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7589e2559265, replyNumber=0, likeNumber=62, createdTime=2022-04-29, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7589e2559265, moduleTitle=Cardiovasc Diabetol：CT血管成像时冠脉周围脂肪组织密度高可预测2型糖尿病患者的心血管事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7589e2559265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383778, encodeId=df751383e78a1, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol:在患有超重和肥胖的2型糖尿病患者中，脂肪和肌肉质量与心血管疾病危险因素的性别相关, objectType=article, longId=724840, objectId=3b07e24840fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b07e24840fa, replyNumber=0, likeNumber=64, createdTime=2022-04-24, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b07e24840fa, moduleTitle=Cardiovasc Diabetol:在患有超重和肥胖的2型糖尿病患者中，脂肪和肌肉质量与心血管疾病危险因素的性别相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b07e24840fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383777, encodeId=cf661383e77b3, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=DOM:2型糖尿病患者早期和持续稳定的血糖控制与主要不良心血管事件(MACE)的减少相关, objectType=article, longId=724839, objectId=0f64e24839a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f64e24839a9, replyNumber=0, likeNumber=76, createdTime=2022-04-24, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f64e24839a9, moduleTitle=DOM:2型糖尿病患者早期和持续稳定的血糖控制与主要不良心血管事件(MACE)的减少相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f64e24839a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383776, encodeId=843c1383e760c, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Metabolism：新冠肺炎合并2型糖尿病患者入院前抗糖尿病药物的使用与死亡率, objectType=article, longId=724709, objectId=29b7e24709c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29b7e24709c1, replyNumber=0, likeNumber=62, createdTime=2022-04-23, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29b7e24709c1, moduleTitle=Metabolism：新冠肺炎合并2型糖尿病患者入院前抗糖尿病药物的使用与死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29b7e24709c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383775, encodeId=10711383e75d0, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=DOM：2型糖尿病患者心血管和肾脏疾病相关的医疗保健使用成本, objectType=article, longId=724708, objectId=3dd1e247086d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dd1e247086d, replyNumber=0, likeNumber=70, createdTime=2022-04-23, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dd1e247086d, moduleTitle=DOM：2型糖尿病患者心血管和肾脏疾病相关的医疗保健使用成本, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dd1e247086d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383774, encodeId=48b21383e7401, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=JCEM：2型糖尿病患者适度低碳水化合物饮食与死亡率的关系, objectType=article, longId=724464, objectId=8879e24464fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8879e24464fb, replyNumber=0, likeNumber=110, createdTime=2022-04-19, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8879e24464fb, moduleTitle=JCEM：2型糖尿病患者适度低碳水化合物饮食与死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8879e24464fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383773, encodeId=513a1383e73a6, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：二甲双胍与高敏心肌肌钙蛋白I和T在2型糖尿病患者中的变化, objectType=article, longId=724355, objectId=145fe2435563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=145fe2435563, replyNumber=0, likeNumber=67, createdTime=2022-04-17, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=145fe2435563, moduleTitle=Cardiovasc Diabetol：二甲双胍与高敏心肌肌钙蛋白I和T在2型糖尿病患者中的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=145fe2435563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383771, encodeId=1dbe1383e71f6, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=JCEM：恩格列净的心血管益处与2型糖尿病患者肠道微生物和血浆代谢物相关, objectType=article, longId=723980, objectId=a051e2398078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a051e2398078, replyNumber=0, likeNumber=63, createdTime=2022-04-12, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a051e2398078, moduleTitle=JCEM：恩格列净的心血管益处与2型糖尿病患者肠道微生物和血浆代谢物相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a051e2398078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383772, encodeId=7ed71383e7296, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Circulation：SGLT2抑制剂可降低2型糖尿病患者的高钾血症风险, objectType=article, longId=723949, objectId=4428e2394910, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4428e2394910, replyNumber=0, likeNumber=94, createdTime=2022-04-12, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4428e2394910, moduleTitle=Circulation：SGLT2抑制剂可降低2型糖尿病患者的高钾血症风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4428e2394910)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383770, encodeId=23151383e701e, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Metabolism：伴有COVID-19的2型糖尿病患者入院前使用降糖药与死亡率的关系, objectType=article, longId=723506, objectId=022ce23506ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022ce23506ad, replyNumber=0, likeNumber=87, createdTime=2022-04-06, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022ce23506ad, moduleTitle=Metabolism：伴有COVID-19的2型糖尿病患者入院前使用降糖药与死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=022ce23506ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2型糖尿病患者

2020-05-29

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：2型糖尿病患者循环中血小板相关和糖尿病相关microRNAs的变化

2022-06-07

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Ann Intern Med：钠-葡萄糖协同转运蛋白-2抑制剂与二甲双胍治疗2型糖尿病患者的心血管结局比较

2022-05-31

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：2型糖尿病患者体重减轻程度和体重变异性与死亡率和主要心血管事件的关系

2022-05-27

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

JCEM：舒张压和ACR是2型糖尿病患者动脉硬化可改变的危险因素

2022-05-25

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

DOM：三联疗法口服药物控制不佳的2型糖尿病患者加用替格列汀的有效性和安全性

2022-05-21

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Stroke：索马鲁肽对2型糖尿病患者卒中亚型的影响

2022-05-20

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

DOM：固定比例的甘精胰岛素联合利司那肽(iGlarLixi)可以改善2型糖尿病患者ß-细胞功能

2022-05-19

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes Obes Metab：LY2963016甘精胰岛素和Lantus®甘精胰岛素在中国1型和2型糖尿病患者中的免疫原性

2022-05-18

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

BMC Med：成人2型糖尿病患者的糖尿病肾病和卒中风险

2022-05-11

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：达格列净、艾塞那肽及其联合应用于2型糖尿病患者降压作用的机制

2022-05-05

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：CT血管成像时冠脉周围脂肪组织密度高可预测2型糖尿病患者的心血管事件

2022-04-29

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol:在患有超重和肥胖的2型糖尿病患者中，脂肪和肌肉质量与心血管疾病危险因素的性别相关

2022-04-24

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

DOM:2型糖尿病患者早期和持续稳定的血糖控制与主要不良心血管事件(MACE)的减少相关

2022-04-24

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Metabolism：新冠肺炎合并2型糖尿病患者入院前抗糖尿病药物的使用与死亡率

2022-04-23

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

DOM：2型糖尿病患者心血管和肾脏疾病相关的医疗保健使用成本

2022-04-23

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

JCEM：2型糖尿病患者适度低碳水化合物饮食与死亡率的关系

2022-04-19

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：二甲双胍与高敏心肌肌钙蛋白I和T在2型糖尿病患者中的变化

2022-04-17

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

JCEM：恩格列净的心血管益处与2型糖尿病患者肠道微生物和血浆代谢物相关

2022-04-12

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Circulation：SGLT2抑制剂可降低2型糖尿病患者的高钾血症风险

2022-04-12

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Metabolism：伴有COVID-19的2型糖尿病患者入院前使用降糖药与死亡率的关系

2022-04-06

科室
- - 订阅+
  - 更多科室
工具
服务